Tenaya Therapeutics is trading 6.9% down at $0.37 on October 30, 2026; the reason for the decline remains unclear.
- The provided price context shows a continued decline from the $0.40 October 29 close.
- Search results included a Piper Sandler Buy item, but it is not evidence of a new catalyst. No clear company-specific announcement or sector-wide explanation was identified.